|
| Investigations with pathological results |
| (i) Erythrocyte sedimentation rate: 107 mm/h |
| (ii) C-reactive protein (CRP): 30.1 mg/L (normal: <6 mg/L) |
| (iii) High sensitivity CRP: 27.0 mg/L (normal: <5 mg/L) |
| (iv) Abdomen computed tomography (finding: chronic |
| periaortitis) |
|
| Investigations with normal or negative results |
| (i) Full blood count (including eosinophil count), lymphocyte |
| subpopulation by flow cytometry of peripheral blood, |
| hemoglobin, serum ferritin |
| (ii) Serum: electrolytes (including Ca and PO4), fasting blood |
| sugar, fasten lipids, urea, creatinine, uric acid, angiotensin |
| converting enzyme (ACE) |
| (iii) Liver and thyroid function tests |
| (iv) Blood coagulation parameters, serum D-dimers |
| (v) Urine chemistry and sediment |
| (vi) Antinuclear antibody (ANA)1, extractable nuclear antigens |
| (ENA), double-stranded DNA, antismooth muscle antibodies |
| (ASMA), antimitochondrial antibodies (AMA), ANCA (-P, -C, |
| -MPO and -PR3), anti-Ro/SSA, anti-La/SSB, rheumatoid |
| factor,anticardiolipin antibodies (IgG and IgM) |
| (vii) Complement levels; serum proteins electrophoretogram; |
| serum immunoglobulins by immune electrophoretogram |
| (including IgA and IgE) |
| (viii) ASTO, RPR, serology for Borrelia burgdorferi, |
| Echinococcus, Toxocara canis, Hepatitis B and C viruses, |
| Epstein-Barr virus and HIV |
| (ix) Serological tumor markers (α-Fetoprotein (α-FP), |
| carcinoembryonic antibody (CEA), Ca19.9, Ca15.3, Ca125) |
| (x) Tuberculin skin test (TST = 2 mm) |
| (xi) Schirmer’s test |
| (xii) Chest imaging (X-ray and computed tomography)2 |
|
